Our team includes renowned cardiologists, geneticists, molecular biologists, biochemists and physiologists. Their focus is on:
- New blood tests for heart attack diagnosis
- Prediction and treatment of heart disease at our hospitals and in our communities
This research translates into:
- Practical benefits
- Improving the quality of treatment
- Diagnosis for people in Christchurch and around the world
As locals, New Zealanders have benefited from our research. In some instances, up to 7 years before global adoption.
Māori are particularly vulnerable to cardiovascular disease (CVD) with an age adjusted rate of death three to four times higher that of the general population in New Zealand. Because of this, Christchurch Heart Institute have an interest and passion to engage with more Māori in their research to identify why and to look at solutions.
Our four research areas
Our clinical projects team investigate the neurohumoral aspects of common cardiovascular diseases including myocardial infarction, hypertension, atrial fibrillation and heart failure
Our Biochemistry and Cell Biology team currently focus on the development of novel biomarker assays for the diagnosis and prognosis of disease, in both clinical and pre-clinical settings.
The Omics and Pacific Heart Health Laboratories are investigating genetic and epigenetic variants that affect an individual's susceptibility to the development and progression of coronary heart disease and heart failure.
Research interests of the physiology team include investigation of the cardiovascular, endocrine and renal integration of circulatory function and pressure/volume control in both health and disease.